The total hip replacement is also referred to as total hip arthroplasty/hip resurfacing. It is a very common surgery that helps to minimize pain and rigidity in the hip joint. The total hip replacement is categorized into four segments, namely, primary hip reconstruction, partial hip reconstruction, hip resurfacing, and revision hip implants.

The primary hip reconstruction procedures are performed to replace the complete hip joint. It consists of three components: a femoral stem, a femoral head, and an acetabular cup. As with the stem, the acetabular cup can be cemented or cementless, which is most common due to its superiority. A partial hip reconstruction is performed when only femoral component of hip joints is to be replaced. This type of implant uses similar modular components to a total hip replacement, however, either a unipolar or bipolar head along with femoral stem is used for this type of surgery. A partial hip prosthesis is comparatively less expensive and consumes less time for implant than a total replacement.

The global hip replacement devices market was valued at USD 4.8 Billion in 2014 and is expected to reach USD 5.9 Billion by 2020, at a CAGR of 3.0% from 2015-2020.

The global hip reconstruction market is broadly classified on the basis of product and geography. Based on product, the market is broadly segmented into primary hip reconstruction devices, partial hip reconstruction devices, revision hip reconstruction devices, and hip resurfacing devices. The primary hip reconstruction devices are subsegmented into cementless and cemented reconstruction devices. The report gives an in-depth analysis of around 40 countries, including the U.S., Canada, Mexico, BRIC, Germany, France, Italy, Spain, the U.K., Russia, Japan, Taiwan, Singapore, South Korea, Australia, Saudi Arabia, UAE, South Africa, and others. North America accounted for the largest share of the global hip reconstruction devices market in 2014. The report also covers the average selling prices of hip implants and hip replacement procedure volumes in all the countries.

The rising pool of hip fractures, hip osteoarthritis, favorable reimbursement scenario, and technological advancements are the major factors responsible for the growth of this market. Additionally, the growing health awareness among masses, along with increase in the spending capacity of the population are propelling the market growth. However, price pressure, risk of complications after surgery, and waiting time for surgery in hospitals are some of the major hindering factors.

The report also provides a detailed competitive landscaping of companies operating in this market. The segment and country-specific company shares, new product launch, M&A, and product approvals of the major companies are detailed. Zimmer Inc. (U.S.), DePuy Synthes (U.S.), Stryker (U.K.), Smith & Nephew (U.K.), B. Braun Melsungen AG (Germany), Corin (U.K.), and Waldemar LINK GmbH & Co. KG (Germany) are some of the key players operating in this market.

These companies have adopted various strategies, such as mergers & acquisitions, and partnership, among others, to accelerate growth in the global hip reconstruction devices market.

Stakeholders

Orthopedic Implants Manufacturing Companies

Medical Device Distributors

Healthcare Institutions (Hospitals, Medical Schools, and Governing Bodies)

Health Insurance Players

Research and Consulting Firms

Regulatory Authorities, such as Food and Drug Administration (FDA)

To know about the assumptions considered for the study, download the pdf brochure

Scope of the Report:

This report categorizes the global market for hip reconstruction devices on the basis of product and region.

Market Segmentation, By Product:

Primary Hip Reconstruction Devices

Partial Hip Reconstruction Devices

Revision Hip Reconstruction Devices

Hip Resurfacing Devices

Market Segmentation, By Geography:

North America U.S. Canada Mexico Brazil Argentina Chile Columbia Paraguay Uruguay

Europe Germany U.K. France Spain Italy The Netherlands Switzerland Russia Belgium Turkey Denmark

Asia-Pacific China India Japan Republic of Korea Australia New Zealand Singapore Vietnam Taiwan Malaysia Indonesia New Zealand



Customization Options:

Along with market data, customize the MNM assessments to meet your company�s specific needs. Customize to get a comprehensive summary of the industry standards and a detailed analysis on the following parameters:

Epidemiology Data

Pateint pool for osteoarthritis (country wise)

Pateint pool for rheumatoid arthritis (country wise)

Procedure Volume

Primary hip reconstruction surgeries (Country Wise) Cemented Primary Hip Reconstruction Surgeries (Country Wise) Cementless Primary Hip Reconstruction Surgeries (Country Wise)

Partial hip reconstruction surgeries Cemented Partial Hip Reconstruction Surgeries (Country Wise) Cementless Partial Hip Reconstruction Surgeries (Country Wise)

Hip resurfacing surgeries (Country Wise)

Revision hip reconstruction (Country Wise)

Product Analysis

Usage pattern (in-depth trend analysis) of products (segment-wise)

Product matrix, which gives a detailed comparison of product portfolio of each company, mapped at country and subsegment level

End user adoption rate analysis of the products (segment-wise and country-wise)

Comprehensive coverage of product approvals, volume data, pipeline products, and product recalls

Brand/Product Perception Matrix

Comprehensive study of customers perception and behavior through our inbuilt social connect tool checking virality and tonality of blogs

Analysis of overall brand usage and familiarity, and brand advocacy distribution (detractor/neutral/familiar)

Porter�s Five Forces Analysis

Detailed account of the nature of bargaining power of the suppliers and the buyers

Degree and intensity of rivalry of the peer players and threat from the new entrants

This global hip reconstruction devices market is analysed and segmented on the basis of product, and region. It analyzes the competitive developments, such as alliance, joint venture, and mergers & acquisitions in the global market. This market is also analyzed with an explicit focus on the high-growth applications and fastest-growing market segments.

A hip replacement is an invasive surgical procedure, used to remove a diseased or fractured hip joint and replace it with an artificial joint or prosthesis. Osteoarthritis is one of the most common factors for hip diseases. Structures within the hip (such as the cartilage or bony joint surfaces) may get damaged due to overuse, trauma, or certain conditions, such as rheumatoid arthritis, tumors, and so on. This may lead to degenerative changes within the hip which can lead to osteoarthritis.

According to OECD Health Statistics, 2012, the hip replacement surgery per 100,000 population is 287. Over the period, it is estimated that the rate of hip reconstruction procedure has increased. The increasing number of patients suffering from osteoarthritis, rheumatoid arthritis, and osteoporosis are some of the major factors for the market growth.

The current trend of inclination towards minimally invasive surgery (MIS) is also one of the important factors for the hip reconstruction market. The MIS, particularly in hip implants, has become a topic of growing interest among the European countries. Recently, the latest implants have been introduced that facilitates promotion of minimally invasive techniques and navigation technique for the patient�s postoperative quality of life. The minimally invasive surgery reduces the amount of soft tissue distraction during a procedure, speeds the patient recovery, and minimizes discomfort.

Some of the significant factors of the MIS are reduced hospital stay, as well as shortened rehabilitation time. Also, the increasing number of patients suffering from osteoarthritis, rheumatoid arthritis, and osteoporosis have led to increase in the adoption rate of hip surgeries in both geriatric as well as young population. Out of 66 million population of France, about 3% of the population is aged above 65 years, and has undergone hip replacement/reconstruction.

The global hip reconstruction devices market was valued at USD 4.8 Billion in 2014 and is expected to reach USD 5.9 Billion by 2020, at a CAGR of 3.0% from 2015-2020.

The hip reconstruction devices market is broadly segmented on the basis of product and geography. Based on product, the global market is classified into primary, partial, revision and hip resurfacing devices. The primary is subsegmented into cementless and cemented reconstruction device. The primary devices commands the largest share in the market, by product.

The report provides a detailed analysis of hip reconstruction devices market for each region and country. Four major regions have been covered in the report, such as North America (the U.S., Canada, Mexico, Brazil, Argentina, Chile, Columbia, Uruguay and Paraguay); Europe (Germany, France, Italy, Spain, Switzerland, the U.K., Netherlands, Belgium, Denmark, Turkey, and Russia); and Asia-Pacific (Japan, China, India, Australia, Republic of Korea, Singapore, Malaysia, New Zealand, Vietnam, Indonesia, Taiwan, and Thailand). A deep-dive analysis on pricing pattern, usage pattern, end user response matrix, market share, government initiatives, product recalls, new product launches, industry trends, and technological advancements have been detailed in the report.

The report also covers the competitive landscape of global market by new product launches, recent developments, and mergers & acquisitions. The major players operating in hip reconstruction devices market are Zimmer Inc. (U.S.), DePuy Synthes (U.S.), Stryker (U.K.), and Smith & Nephew (U.K.), B. Braun Melsungen AG (Germany), Corin (U.K.), and Waldemar LINK GmbH & Co. KG (Germany).

To speak to our analyst for a discussion on the above findings, click Speak to Analyst